These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 25082635)
21. Phytochemical profile and therapeutic potential of Viscum album L. Nazaruk J; Orlikowski P Nat Prod Res; 2016; 30(4):373-85. PubMed ID: 25813519 [TBL] [Abstract][Full Text] [Related]
22. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings. Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069 [TBL] [Abstract][Full Text] [Related]
23. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador). Gorter RW; van Wely M; Stoss M; Wollina U Am J Ther; 1998 May; 5(3):181-7. PubMed ID: 10099057 [TBL] [Abstract][Full Text] [Related]
24. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286 [TBL] [Abstract][Full Text] [Related]
25. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs. Kleinsimon S; Kauczor G; Jaeger S; Eggert A; Seifert G; Delebinski C BMC Complement Altern Med; 2017 Jan; 17(1):26. PubMed ID: 28061770 [TBL] [Abstract][Full Text] [Related]
26. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer. Thronicke A; Steele ML; Grah C; Matthes B; Schad F BMC Complement Altern Med; 2017 Dec; 17(1):534. PubMed ID: 29237435 [TBL] [Abstract][Full Text] [Related]
27. Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus). Christen-Clottu O; Klocke P; Burger D; Straub R; Gerber V J Vet Intern Med; 2010; 24(6):1483-9. PubMed ID: 21039860 [TBL] [Abstract][Full Text] [Related]
28. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador. Maldacker J Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531 [TBL] [Abstract][Full Text] [Related]
29. Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis. Vergara-Barberán M; Lerma-García MJ; Nicoletti M; Simó-Alfonso EF; Herrero-Martínez JM; Fasoli E; Righetti PG J Proteomics; 2017 Jul; 164():52-58. PubMed ID: 28571969 [TBL] [Abstract][Full Text] [Related]
30. Patients are talking about ... Iscador (mistletoe). Decker G Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624 [TBL] [Abstract][Full Text] [Related]
31. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations. Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471 [TBL] [Abstract][Full Text] [Related]
32. A 21-year course of Merkel cell carcinoma with adjuvant Viscum album extract treatment: A case report. Werthmann PG; Kindermann L; Kienle GS Complement Ther Med; 2018 Jun; 38():58-60. PubMed ID: 29857880 [TBL] [Abstract][Full Text] [Related]
33. Phytochemical screening and effect of Viscum album L. on monoamine oxidase A and B activity and serotonin, dopamine and serotonin receptor 5-HTR1A levels in Galleria mellonealla (Lepidoptera). Szurpnicka A; Wrońska AK; Bus K; Kozińska A; Jabłczyńska R; Szterk A; Lubelska K J Ethnopharmacol; 2022 Nov; 298():115604. PubMed ID: 35944736 [TBL] [Abstract][Full Text] [Related]
34. Effects of Iscador preparations on the reactivity of mouse immune system. Gren A Neuro Endocrinol Lett; 2009; 30(4):530-4. PubMed ID: 20010495 [TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of Viscum album mother tincture as an antihypertensive: a pilot study. Poruthukaren KJ; Palatty PL; Baliga MS; Suresh S J Evid Based Complementary Altern Med; 2014 Jan; 19(1):31-5. PubMed ID: 24647376 [TBL] [Abstract][Full Text] [Related]
36. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells. Felenda JE; Turek C; Stintzing FC J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914 [TBL] [Abstract][Full Text] [Related]
37. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro. Kelter G; Fiebig HH Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523 [TBL] [Abstract][Full Text] [Related]
38. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks. Stoss M; van Wely M; Musielsky H; Gorter RW Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457 [TBL] [Abstract][Full Text] [Related]
39. Cytokine release of a keratinocyte model after incubation with two different Viscum album L extracts. Gorter RW; Joller P; Stoss M Am J Ther; 2003; 10(1):40-7. PubMed ID: 12522519 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10. Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]